Damora Therapeutics, Inc. (DMRA)

Damora Therapeutics Statistics

Total Valuation

DMRA has a market cap or net worth of $1.53 billion. The enterprise value is $998.54 million.

Market Cap	1.53B
Enterprise Value	998.54M

Important Dates

The last earnings date was Tuesday, May 12, 2026, after market close.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

DMRA has 61.55 million shares outstanding. The number of shares has increased by 689.73% in one year.

Current Share Class	61.55M
Shares Outstanding	61.55M
Shares Change (YoY)	+689.73%
Shares Change (QoQ)	+2,216.95%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	64.95%
Float	41.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.96
P/TBV Ratio	4.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.48

Current Ratio	22.48
Quick Ratio	22.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -89.50% and return on invested capital (ROIC) is -15.41%.

Return on Equity (ROE)	-89.50%
Return on Assets (ROA)	-14.70%
Return on Invested Capital (ROIC)	-15.41%
Return on Capital Employed (ROCE)	-12.66%
Weighted Average Cost of Capital (WACC)	12.55%
Revenue Per Employee	n/a
Profits Per Employee	-$33.58M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DMRA has paid $90,000 in taxes.

Income Tax	90,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +729.33% in the last 52 weeks. The beta is 1.51, so DMRA's price volatility has been higher than the market average.

Beta (5Y)	1.51
52-Week Price Change	+729.33%
50-Day Moving Average	24.88
200-Day Moving Average	19.13
Relative Strength Index (RSI)	49.66
Average Volume (20 Days)	387,161

Short Selling Information

The latest short interest is 1.29 million, so 2.10% of the outstanding shares have been sold short.

Short Interest	1.29M
Short Previous Month	1.19M
Short % of Shares Out	2.10%
Short % of Float	3.13%
Short Ratio (days to cover)	4.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-64.77M
Pretax Income	-235.00M
Net Income	-235.09M
EBITDA	-64.75M
EBIT	-64.77M
Earnings Per Share (EPS)	-$24.47

Balance Sheet

The company has $532.90 million in cash and n/a in debt, with a net cash position of $532.90 million or $8.66 per share.

Cash & Cash Equivalents	532.90M
Total Debt	n/a
Net Cash	532.90M
Net Cash Per Share	$8.66
Equity (Book Value)	511.60M
Book Value Per Share	6.29
Working Capital	511.60M

Cash Flow

Operating Cash Flow	-24.89M
Capital Expenditures	n/a
Depreciation & Amortization	22,000
Net Borrowing	n/a
Free Cash Flow	-24.89M
FCF Per Share	-$0.40

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DMRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-689.73%
Shareholder Yield	n/a
Earnings Yield	-15.35%
FCF Yield	-1.62%

Analyst Forecast

The average price target for DMRA is $43.14, which is 73.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$43.14
Price Target Difference	73.39%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 30, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date	Aug 30, 2024
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	2